Bombay HC quashes FDA order, allows J&J to produce baby powder - Mumbai News
by IANS | Updated Jan 11, 2023
A division bench of Justice Gautam S. Patel and Justice Shivkumar G. Dige termed the Food & Drugs Administration's action as unreasonable and therefore "arbitrary" - while setting it aside, paving the way for J&J to resume production and sell its baby powder.
It observed that it is not reasonable that the moment one sample from a batch is found to be of substandard, the company's manufacturing licence is cancelled.
"This seems to us to be extremea and there's nothing to show that FDA has consistently adopted such a stringent standard with other J&J products or other manufacturers," said the judges.
In a drastic move on September 15, 2022, the FDA Joint Commissioner had cancelled J&J's licence to manufacture baby powder products and also told the company to recall its market stocks, after which the company challenged the decision in the high court.
J&J had come under the FDA radar in November-December 2018 after random checks in Pune and Nashik when it collected samples for testing.
When an October 2018 batch sample was tested again after 11 months (September 2019), its pH level was found to be higher than the permissible levels, but J&J was informed about it in January 2020 and asked for a re-test.
However, the FDA issued a show-cause notice to J&J after over a year in February 2021, gave a hearing in July 2022, and ordered cancelling of its manufacturing licence in September 2022.
Observing that while a watchdog like FDA is necessary, Justice Patel and Justice Dige said that proceedings cannot be protracted with a "harsh delay" like this for weeks and months, and the watchdog must do its job properly to guard and protect the interests of the consumers.
The judges also frowned at "the now usual excuse of Covid" on the delays for a test on a sample collected in October 2018 - well before anyone could imagine Covid - and the delays continued until 2022.
- Passenger tweets 'flight hijacked', arrested at IGI
- In latest round of layoffs by tech majors, SAP cutting 2,900 jobs and IBM 3,900
- FAIFA welcomes govt initiatives to curb gold and mobile smuggling, appeals for similar measures for cigarettes
- Vertex, Tata Chemicals Europe sign major low carbon hydrogen offtake agreement
- GitHub crosses 100 mn developers, over 10 mn in India alone
- Global output growth to fall to 1.9% in 2023 from 3%: UN report
- J&K approves Rs 39-cr mega project to boost commercial floriculture
- Centre defers move to bring in fact check rules amid protests
- 9 out of 10 individual traders in F&O segment making losses
- Adani evaluating remedial and punitive action against Hindenburg Research